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Antibiotics, Rational Drug Use and the Architecture of Global 
Health in Zimbabwe 
 
Abstract 
Rising concerns around antimicrobial resistance (AMR) have led to a renewed push to 
rationalise antibiotic prescribing in low- and middle-income countries (LMICs). There is 
increasing unease in conceptualising antibiotic use as individuals behaving ‘(ir)rationally’, 
and recognition that rising use is emergent of and contributing to wider economic and 
political challenges. But in between these individual and societal level ‘drivers’ of antibiotic 
use is an everyday articulation of care through these substances, written-in to the scripts, 
delivery chains and pedagogics of global healthcare. This article focuses on these everyday 
‘architectures’ that over time and across spaces have knitted-in antibiotics and rhetorics of 
control that inform current responses to AMR. Based on historically informed ethnographic 
research in Zimbabwe, we examine points of continuity and change between 20th Century 
rational drug use (RDU) discourses and contemporary socio-political formations around 
AMR and antimicrobial stewardship (AMS), paying particular attention to their co-evolution 
with the process of pharmaceuticalisation. We illustrate how the framework and techniques 
of RDU were embedded within programmes to increase acc ss to essential medicines, and as 
such complemented Zimbabwe’s building of one of Africa’s strongest postcolonial health 
systems. Whilst RDU was focused on securing health and safety of patients and affordability 
for systems, AMS programmes aim to secure medicines. Continuous across both RDU and 
AMS programmes is the persistent rhetoric of ‘irratonal use’ by frontline prescribers. Health 
workers in Harare are attuned to the values and langu ge of these programmes, but their 










research illustrates the struggle to optimise antibiotic use within current framings for action. 
We propose a reconfiguring of the architecture of gl bal health such that frontline prescribers 
are able to provide ‘good’ care without necessarily turning to antibiotics. To design-out 
antibiotic reliance would require attention beyond rationality, to the redrafting of blueprints 
that inscribe practice. 
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Antimicrobial resistance (AMR) has emerged as a key health challenge of our time. The 
WHO’s Global Action Plan on AMR (2015:VII) observes that drug resistance “threatens the 
very core of modern medicine and the sustainability of an effective, global public health 
response to the enduring threat from infectious diseases”. AMR has been widely reported to 
be accelerated by the ‘irrational’ use of antimicrobial medicines, and considerable research, 
policy and interventions have been mobilised to optimise antimicrobial use, particularly 
antibiotics, in human and animal medicine (IACG, 2019; OIE, 2016; O’Neill, 2016; WHO, 
2015). Low- and middle-income countries (LMICs) have seen a significant rise in antibiotic 
use in recent decades (Klein et al, 2017) and have been identified as particular targets for 
intervention. Following the recommendations of the global action plan, many countries have 











In LMIC healthcare settings, numerous studies have highlighted widespread 
‘irrational’ antibiotic prescribing, increasingly so since AMR rose to prominence on the 
global health agenda (e.g. Johansson et al, 2016; Mashalla et al, 2017; Sulis et al, 2020). Such 
accounts benchmark practice against a conception of ‘(ir)rationality’ based on an assessment 
of the alignment of prescriptions with clinical need. Efforts to address irrational prescribing 
have a long history dating back to their discovery (Podolsky, 2015). In the current era of 
AMR concern, these efforts operate under the framework of ‘antimicrobial stewardship’ 
(AMS). Broom et al (2020, p.1) observe that current AMS approaches focus on “surveillance, 
restriction and correction of antibiotic usage”. In this assemblage, surveillance, which 
renders antibiotic use legible via aggregate data on individual behaviour, tends to favour 
restrictive and corrective interventions including training/education, audit/feedback, 
formulary restrictions, guideline implementation and decision-support technologies (Cox et 
al, 2017; Wilkinson et al, 2018).  Systematic reviews suggest such interventions can reduce 
prescribing, particularly when performed in tandem, but evidence in LMICs remains limited 
and difficult to draw conclusions from, and the sustainability of such reductions is not well 
understood (Akpan et al, 2020; Rowe et al, 2018; Van Dijck et al, 2018; Wilkinson et al, 
2018). Reviews of national action plans further warn of misalignment between the global 
AMR agenda and local policy priorities, which has re ulted in fragmentary implementation at 
national level (Ahmad et al, 2019; Pokharel et al, 2019).   
Anthropologists and other social scientists have long contested narrow framings of 
‘(ir)rationality’ as neglecting the wider roles tha antibiotics take on through their circulation 
in social, political and economic life (Geest & Whyte 1989; Whyte et al, 2002). In response 
to escalating concern about AMR, an expanding body of qualitative studies around the world 
has enhanced our understanding of these wider ‘drivers’ of antibiotic use, including 










alternatives to antibiotic use (Broom, et al, 2017; Haenssgen et al, 2020; Pearson & Chandler, 
2019; Krockow & Tarrant, 2019; Rodrigues, 2020). Broadly, these studies contribute to an 
understanding of ‘situated rationalities’ (Lawson, 1997) of antibiotic use that, while irrational 
from a biomedical perspective, are coherent within co texts of poverty and resource scarcity. 
These broader issues are understood to prioritise present antibiotic use over future efficacy 
and explain the limited traction of restrictive and corrective interventions (Broom et al, 2019, 
2020; Chandler, 2019; Ledingham et al, 2019; Will, 2018). There is growing recognition that 
to bring about sustainable reductions in antibiotic use, ‘AMR sensitive’ interventions that 
respond to wider dependencies on antibiotics are needed (e.g. IACG, 2019; World Bank, 
2019). 
In between these conceptualisations of ‘drivers’ of antibiotic use through individual 
(ir)rationality and wider social, economic and political ‘drivers’, lies the everyday articulation 
of healthcare through antibiotics. Technical apparatus – in the form of clinical guidelines, 
delivery chains and pedagogics – can easily be overlooked in studies of behaviour and ‘the 
social’. However, scholars of science and technology draw attention to these devices as 
scripts that are written and enacted. They are part of an ‘architecture’ of global health that 
follows particular imperatives, priorities and models of change that are retraced over time 
such that certain ways of knowing and doing become tak n for granted (Dixon & Chandler, 
2019; Herrick & Reubi, 2017). These ‘grooves’ can be traced back to previous health regimes 
(for example, ‘international health’), yet as commentators have argued, continuity between 
eras has tended to have been overshadowed in recent years by narratives emphasising 
discontinuity and rupture (Geissler 2015; Greene, 2015). AMR has compelled critical 
reflection on the historical processes through which antibiotics have become embedded 
within systems of care globally. However, to date few accounts beyond high-income settings 









durée of interventions on antibiotic prescribing to explicate how these cumulative processes 
inflect efforts to rein in AMR in the present.  
In this research, we draw attention to the ways in which antibiotics have been written-
in to the architecture of global health as the legacy of the essential drugs movement of the 
1970s and 80s. In particular, we foreground the technical apparatus that has endured from 
when the thrust of the essential drugs movement tured from selection of drugs to matters of 
implementation, which entailed greater attention to technical issues of procurement, 
distribution, safety, and ‘rational drug use’ (RDU) (Laing, 2003). A focus on the architectures 
of global health enables analysis of the writing-in of antibiotics through a long and complex 
process of pharmaceuticalisation (Biehl, 2006; Greene, 2015) that has been accelerated by the 
preference in the field of ‘global health’ for narrow technological interventions, which has 
seen care in LMICs largely stripped to the provision ( r not) of medicines (Denyer Willis & 
Chandler, 2019; Dixon & Chandler, 2019; Gouws, 2004). The development and deployment 
of clinical guidelines, many with iterations dating back to the 1970s and 80s, have had a 
critical role in creating and sustaining this architecture under different regimes of RDU and 
more recently AMS. Understanding how these regimes converge and connect to produce 
healthcare that is articulated through antibiotics in particular settings is critical if concerns 
about the rise of AMR are to be taken seriously. 
Our analysis is based on historically informed ethnographic research centring on in-
depth fieldwork conducted in Harare, Zimbabwe in 2019. We embed qualitative and 
quantitative data from clinic and hospital settings within a broader historical analysis of the 
health system, incorporating perspectives of policymakers, health planners, scientists, facility 
managers, doctors and nurses. Through this wide-angle lens, we follow discourses around 
RDU along both temporal and spatial axes, in the process developing ‘(ir)rationality’ as a 









consequences as deployed and across time and space.Firstly, we trace RDU back to 
Zimbabwe’s particularly successful essential drugs programme in the 1980s (WHO, 1995) in 
order to evaluate its construction in public health, its embedding within the expansion of the 
country’s postcolonial healthcare system via the development of a national treatment 
guideline and surveillance apparatus, and its subsequent co-evolution with the political, 
economic and technical agendas of global health amidst economic downturn, culminating in 
current discourses around AMR/AMS. We then follow RDU discourses into to the ‘normal 
emergency’ (Fiereman, 2011) of clinic and hospital settings, first identifying patterns of non-
indicated antibiotic use, before interpreting these a  clinicians pushing back against 
increasingly abstract, distanced principles of RDU to provide care amidst mounting scarcity, 
vulnerability and pharmaco-dependencies. That such practices are nonetheless being 
configured in the era of AMR as irrational, requiring restrictive and corrective AMS 
interventions (Broom et al, 2020), reflects a very different architecture within which the 
logics and apparatuses of RDU now feature, one which is alarmingly unresponsive to the 
pharmaceuticalisation and fragmentation of care. This in turn leads us to critically reflect on 
the continued use of ‘(ir)rationality’ as an epistemic framework for understanding antibiotic 
prescribing and to call for a reform of AMS that aims to design-out antibiotics through 
attending to architectures, context and global south perspectives. 
 
Study Setting and Design 
Zimbabwe 
Zimbabwe is a low-income country with a population of 14.9 million, of which 1.5 million 
live in the capital, Harare. Following independence in 1980, huge strides were made in 
expanding access to healthcare, moving from an urban, curative and racially-biased health 










(Loewenson et al, 1991; Mutizwa-Mangiza, 1999; Woelk, 1994). A core part of this 
restructuring was a successful essential drugs programme with a strong emphasis on RDU. 
Zimbabwe came to boast one of Africa’s strongest healt  systems, with thriving teaching 
hospitals, excellent laboratory capacity, a well-trained workforce and a robust PHC 
infrastructure. However, the achievements of the 1980s–90s were undone by political 
repression by the Mugabe regime, structural adjustmen  (which decreased public spending in 
favour of privatisation), hyperinflation, declining donor support and HIV and AIDS (Green, 
2016). Life expectancy remained <50 through the 2000s, with arguably the worst period the 
cholera outbreak in 2008-9 which, caused by neglected water and sanitation infrastructure, 
killed over 4000, disproportionally in areas of political opposition in Harare (Chigudu, 2020). 
Prospects appear little better today, with a lack of medicines and supplies, regular health 
worker strikes, and rising user fees and pharmaceuticals costs (Kidia, 2018).  
 
Study Design 
The research on which this article is based was conducted in the context of a multi-country 
study on febrile illness and antimicrobial use in Africa and Asia called X (Anonymous, 
2020). We used a multi-sited ethnographic approach (Marcus, 1995) that centres here on 
fieldwork conducted in Harare between January 2019 and September 2019, but which draws 
upon insights gained from the broader X study as they crystallised through its lifespan 
between 2017-2021. Our multi-sited approach was design d to follow discourses around the 
use of antibiotics spatially and temporally, which entailed an adaptive research process that 
deployed purposive and snowball sampling techniques and was responsive to findings as they 
emerged. The research was co-produced by a team that included two UK-based European 
anthropologists (Author 1 and Author 5), a European clinical scientist based in Zimbabwe 










(Author 3), supported by the wider X consortium. Each brought knowledge, experience and 
networks to the table that made this research possible, but also in a way that may have been 
different had the team dynamics between otherwise. On  feature of our collective networks 
was their bias towards urban biomedical elites. While t is had advantages, including 
facilitated access to policy networks, administrative centres and central hospitals, our 
findings lack the inclusion of rural, more peripheral local perspectives. This is a limitation we 
make explicit when relating our findings.  
The first phase of research involved in-depth interviews with stakeholders and 
analysis of policy and programme documents to understand the Zimbabwean health system, 
the history of RDU and its co-evolution with other international and global health discourses. 
JD and SM purposively sampled representatives of the Zimbabwe AMR Core Group (n=2), 
the Ministry of Health and Child Care (MoHCC) (n=1), the National Medicines and 
Therapeutics Policy Advisory Committee (NMTPAC) (n=2), the Zimbabwe Essential Drugs 
Action Programme (ZEDAP) (n=2) and scientists (n=3) (total n=10). Interviews were 
conducted in English at participants’ places of work r virtually, most of which took place 
immediately following the obtaining of written informed consent. Follow-up interviews were 
conducted where possible to pursue emerging themes and assess changes in views over time 
(total interviews n=17). Documents were identified through an iterative process involving 
literature searches, bibliography reviews and recommendations from interviewees. The latter 
were valuable for identifying grey literature documenting the development of ZEDAP and 
the national surveys it conducted periodically since the late 1980s. A tabulated overview of 
policy documents and interviews is available here.   
 The second phase involved fieldwork in Harare Central Hospital (henceforth Harare 
Central) and two purposively selected public clinics in Harare City (Figure 1), during which 









(n=16), doctors (n=5), pharmacists (n=4) and facility managers (n=4). Author 1 and 3 worked 
together to ensure Shona language interactions were accurately captured, whilst all in-depth 
interviews were conducted in English. Public clinics in Harare are nurse-led, doctor-
supported facilities in which most prescribing is performed by nurses, which has been the 
case since the integration of curative and preventative services following independence 
(Zimbabwe MoH 1984). Clinic 1 is situated in Mbare, a high-density suburb well-known as a 
travel hub and for its sprawling marketplaces. This clinic serves a constituency of around 
50,000, but in reality, it provides healthcare for far more because of the influx of travellers, 
both from within Zimbabwe and from neighbouring countries. Clinic 2 serves around 30,000 
and is located in Budiriro, a high-density suburb in the south-west that was among the worst-
hit during the 2008-2009 cholera outbreak. Budiriro was also a hotspot of another cholera 
outbreak during August-October 2018 and since the start of 2018 has experienced an ongoing 
typhoid outbreak. Harare Central is a referral hospital that admits patients from across 
Zimbabwe. As such, it is the hospital to which most patients from Harare clinics are referred 
to if they need care beyond the capacity of clinic services. Unlike clinics, the vast majority of 

































Between June 2019 and September 2019, we observed 370 outpatient consultations at Clinic 
1 and 371 at Clinic 2 (n=741). While this sample was not statistically defined and did not 
involve specific daily targets (to allow us to follow up events of interest as they occurred), 
around 20 consecutive consultations were observed per ay, alternating between morning and 
afternoon starting times, with both weekdays and weekend days included, to capture 
variations in presentations. In addition to field notes, basic information about consultations 
was captured, including patient age and sex, consultation length, presenting symptoms, tests 
and observations, diagnosis, treatment and referral information. This quantitative data was 
used to identify patterns of antibiotic prescription, including use beyond the national 










observed doctors in Harare Central’s casualty department and medical wards to learn how 
antibiotics were prescribed and courses adjusted. Bcause antibiotics are prescribed in many 
areas of the hospital, we did not capture quantitative data but instead draw on available 
secondary data.  
Data analysis was conducted an ongoing basis overlapping with data collection. 
During the first phase, stakeholder interviews and policy/programme documents were entered 
into NVivo 12 for preliminary thematic analysis, whic  was used to refine questions for the 
in-depth fieldwork phase. During the fieldwork phase, quantitative data was periodically 
analysed using R to identify patterns of antibiotic prescribing, the results from which were 
fed back into observation and interviews, including follow-up stakeholder interviews. As the 
project progressed, we moved back and forward between working hypotheses and data, 
gradually generating codes of progressively higher orders of abstraction to explain and 
theorise findings. These were fed back to facility staff, local health authorities and 
stakeholders, a process which in turn informed this article. The study received ethical 
approval from the London School of Hygiene and Tropical Medicine Ethics Committee (ref. 
41616), the Biomedical Research and training Institute, Zimbabwe (ref. AP146/2018) and the 
Medicines Research Council of Zimbabwe (ref. MRCZ/A/2288). For further details on 
methodology and design of the broader study, a protocol is available on the X study website. 
In the following, all participant names are replaced with pseudonyms.  
 
Rational Drug Use in Zimbabwe 
Since antibiotics were discovered, they have taken on central ‘infrastructural’ importance 
enabling healthcare as we know it (Chandler, 2019). Following the WHO’s Essential Drugs 
Programme in 1972, antibiotics became the cornerstone of essential drug lists around the 










development (Greene, 2015). At the same time, concerns around antibiotic use had been 
raised since their discovery (Podolsky, 2015) and received greater attention in LMICs in the 
1980s when the focus of essential drugs programmes turned towards procurement, 
distribution safety and ‘rational’ use (Laing, 2003). At a conference in Nairobi, 1985, rational 
use was defined as: “patients receive medications appropriate to their clinical needs, in doses 
that meet their own individual requirements for an adequate period of time, at the lowest cost 
to them and their community” (WHO, 1985). An emergent RDU movement that included the 
WHO, Health Action International (HAI) and International Network of Rational Use of 
Drugs (INRUD) proceeded to engage with medical and economic dimensions of the RDU 
problem (Laing, 1990). A key concern was in reducing the influence of industry on clinical 
care, whose propriety interests and actions were und rstood to drive both increasing ‘excess’ 
use globally as well as persisting inequities in ‘access’, by implementing regulation to 
separate dispensing and prescribing, promote generic drug use and limit numbers of drugs 
registered (Greene, 2015; Trap, Hansen & Hogerzeil 2002). Zimbabwe came to be hailed a 
particular success story in implementing its essential drugs programme. The first Essential 
Drugs List of Zimbabwe (EDLIZ), adopted in 1985 by the newly-formed NMTPAC and 
updated every few years since, specified a limited number of generic medicines and the level 
of care at which they should be available. Unlike in most LMICs, EDLIZ also contained 
detailed empirical treatment guidelines, with RDU explicitly a core principle. To integrate 
EDLIZ into the Zimbabwe’s expanding health system, ZEDAP was established in 1986 with 
support from the Danish government (Danida) and the WHO.  
 Made up of international and national representatives, ZEDAP took a ‘bottom-up’ 
approach that began with building capacity at the primary level. Much of ZEDAP’s work in 
the 1980s involved a training programme for nurses and pharmacists that was co-produced by 









deprived areas (Laing & Ruredzo, 1989). ZEDAP also reached out to hospital specialists to 
encourage wider uptake of EDLIZ, especially among doctors (Mutizwa-Mangiza, 1999), and 
indeed ZEDAP’s work quickly spanned the whole health system, with regular national 
surveys based on WHO/INRUD (1993) indicators to monitor programme effects (Trap et al. 
1997). By the mid-1990s, the tone was extremely optimis ic. An Essential Drugs bulletin 
(ZEDAP & MoHCC 1995:17) boasted: “[v]isit any government health facility and find a 
well-thumbed copy of [EDLIZ]”, citing a 1993 survey which found 94% of drugs were 
prescribed by generic name and 97.5% were in EDLIZ. It also claimed the Zimbabwean 
experience “provides valuable insight for other countries wishing to promote rational drug 
use” (WHO 1995, p.17). However, the Zimbabwean experience also highlighted the 
contingency of such successes. ZEDAP members expressed that successes were dependent 
on strong leadership and political will, the unity of clinical, lab and pharmacy professions, 
and repeated interventions. All became harder to sustain as the 1990s wore on, with 
economic decline, structural adjustment, political turmoil and HIV placing unprecedented 
strain on the health system, and Danida pulled out of ZEDAP in 1999. Reflecting this shifting 
situation, surveys 1991–2004 showed that ZEDAP’s target of ensuring 80% drug availability 
was met in 1991 but not since (Trap et al, 1997); the surveys also demonstrate declining 
levels of adherence to EDLIZ for key indications, variable rates of antibiotic prescribing and 
consistent increases in medicines per prescription (Table 1).  
 [Author 1] and [Author 2] spent many hours in the office of Dr Ndou, a consultant 
physician who had sat on the NMTPAC, taken part in evising EDLIZ and been involved in 
recent debates and discussions around AMR. Dr Ndou related the challenges of ensuring the 
rational use of medicines since the 21th Century. Firstly, public sector resource shortages had 
led to frequent medicine stockouts, undermining adherence to EDLIZ; a lack of diagnostics 










Secondly, the decline of the public sector had seen a corresponding rise in private and 
informal sectors, where there were fewer incentives to use medicines ‘rationally’. Third, the 
proliferation of global health programmes that had arrived on the back of HIV had become 
increasingly difficult to manage. Programmes for HIV and TB, malaria, STIs, diarrhoeal 
diseases, the Integrated Management of Childhood Illness (IMCI) – each had brought its own 
medicines and guidelines and, often in partnership with industry, generally favoured 
technological solutions to address their priority area. Dr Ndou was reflexive about her 
positioning as an urban-based, public sector health planner, but was nonetheless frustrated 
that these combined factors had worked to undermine the centralised control EDLIZ had 
previously enabled over medicine selection and use with the “bigger picture” of the health 
system in mind. For instance, often programmes would start on the ground and then, having 
already changed medicines and prescribing, had to be retrospectively absorbed into EDLIZ, 
regardless of whether this was ‘rational’ for the broader system (in both medical and 
economic senses). Additionally, amidst these detrimntal changes, various pressures had led 
to more injectable and broad-spectrum antibiotics being indicated and available at lower 
levels of care (elaborated below). Dr Ndou, in short, described an increasingly fragmented 
health system that both limited implementation of EDLIZ and was reflected within its pages. 
“We’ve lost control!”, Dr Ndou exclaimed. 
During our fieldwork, ‘AMR’ was a new policy object on the radar of Zimbabwe’s 
public health community but being increasingly discussed. Following the WHO’s GAP, in 
2016 an AMR core group was established, with members from human, animal and 
environmental health sectors, supported by the Global Antimicrobial Resistance Partnership 
(GARP), which was simultaneously working with multiple countries. Firstly, a situation 
analysis was conducted (Zimbabwe AMR Core Group, 2016), which reported resistance to 










terms of antibiotic use, the situation analysis repo ts on a knowledge, attitudes and practice 
(KAP) survey, which found knowledge of AMR and antibiotic use among doctors, nurses and 
pharmacists was generally high. However, the report also documented widespread irrational 
prescribing, based on a point prevalence survey of hospital antibiotic use and results from 
national surveys 2011–2015 (all facility types). The latter suggest that adherence to EDLIZ 
for mild ARIs and diarrhoea was highly variable and, as can be seen in Table 1, appeared 
lower on aggregate than the 1990s and 2000s (Table 1). Zimbabwe’s national action plan was 
launched in 2017 (Zimbabwe AMR Core Group 2017), which emphasised the need to 
improve access to antimicrobials but also, with a focus on the behaviours of end users, 
stressed that “widespread irrational antimicrobial use” needed to be targeted. At the time of 
writing, existing and planned initiatives generally fell into the categories of “surveillance, 
restriction and correction” (Broom et al. 2020), including surveillance of resistance profiles, 
awareness campaigns and hospital therapeutics committees. To understand the context that 
this narrow framing of “irrational use” configured as a target for intervention, we turn now to 

































Context of Antibiotic Prescribing  
A Normal Emergency 
“We nurses are a frustrated group” commented Sister Ch nai, who was working in the 
outpatient department (OPD) of Clinic 1 with [Author 1] watching. She had just finished the 
time-consuming task of filling the IMCI register for a baby girl who, after arriving with a 
high fever and difficulty breathing, had been classified as having severe pneumonia, which 
meant a shot of gentamicin and benzylpenicillin andurgent referral to Harare Central. Sister 
Chenai’s comment was understandable. The daily rhythms of the clinics exemplified what 
Fiereman (2011) has described as the “normal emergency” of African public service 
provision. There was often only one nurse in OPDs because of short staffing, who with 
usually less than 10 minutes per patient (Table 2), had to obtain a clinical history and perform 










programme-specific registers. This was despite longqueues, electricity and water shortages, 
and medicine stockouts. Patients were prescribed what as available, and where necessary 
they were sent to a retail pharmacy to purchase medicin s. These medicines might not 
actually be bought given the rising medicines costs, which often meant that patients 
eventually came back to the clinic, sicker than before. In fact, people were often making use 
of the informal sector and only coming to the clinic if severely ill. Because of rising user fees, 
if they could afford to come, could often only come once.  
 The situation at Harare Central was no better. With around 2000 doctors and nurses 
and a further 1000 paraclinical staff, Harare Central offers a greater range of outpatient and 
inpatient services than at the primary level within its four constituent hospitals: paediatrics, 
adults, maternity and psychiatrics. Despite its size and centrality, the hospital faces severe 
resource shortages, including stockouts, limited diagnostics, understaffing and regular strikes. 
The casualty department queues were comparable to th  clinics, with even sicker patients, 
and the wards were frequently overflowing, particularly during outbreaks. Patients could be 
prescribed antibiotics at many points along the pathw y through the hospital, including by the 
casualty officer (who triages patients), by the specialist doctor or paediatrician (who makes 
admission decisions) and at any stage as an inpatiet. Following admission, patients were 
reassessed and changes (including to antibiotic regmens) were made based on clinical 
condition and available test results, as well as what t e patient’s family could afford and what 
was available in the hospital pharmacy. 
 
Background Prescribing Figures 
While we did not seek to audit prescribing (to distinguish ‘correct’ and ‘incorrect’) or 
undertake a statistically rigorous comparison betwen Clinic 1 and 2, we identified 










prescribed at least one antibiotic were similar (56% and 58%), and both slightly higher than 
the average of 52% (95% CI: 51%–53%) identified in a review of prescribing in primary care 
in LMICs (Sulis et al, 2020). The prescribing rates b tween the two clinics were comparable 
when broken down by age and sex, but differences becam  more apparent when broken down 
by diagnosis and antibiotic selection. Figure 3a shows more respiratory infections and 
sexually transmitted infections (STIs) were diagnosed at Clinic 1. Clinic 2 had a higher 
number of presentations due to diarrheal illness and gastrointestinal symptoms, which may be 
explained by the area’s poor water supply, sanitation and typhoid epidemic.  Figure 3b 
further suggests that the choices of antibiotics were logical given the distribution of 
diagnoses. For instance, amoxicillin is indicated for numerous conditions including 
pneumonia, tonsillitis and ear infections and is thus expectedly the most prescribed in both 
clinics. The greater proportion of ceftriaxone and doxycycline prescribed at Clinic 1 appears 
related to these being first line treatment for sexually transmitted infections (STIs); and at 
Clinic 2, the greater use of metronidazole and azithromycin is associated with the higher rates 
of diarrheal illness and gastrointestinal symptoms.  
While antibiotic selection suggested a keen familiarity with the biomedical 
indications of antibiotics, we also found that clinic urses were frequently treating mild acute 
respiratory infections (ARIs) and diarrhoea with antibiotics when generally not indicated by 
EDLIZ (Figure 3a). This finding is consistent with low levels of EDLIZ adherence for mild 
ARIs and diarrhoea that have been highlighted by natio l surveys over the last three decades 
(Table 1). Other non-indicated illnesses treated with antibiotics include abdominal pain, 
chicken pox, vomiting and rashes (Figure 3a). Beyond evaluating prescribing against 
diagnoses, it was evident from our observations that to rrive at a full diagnosis ‘by the book’ 
(i.e. EDLIZ) given the limited time and resources was often impossible for the nurses in 









analysis (Zimbabwe AMR Core Group, 2016) that knowledge of antibiotics and their uses 
was high but that such knowledge did not necessarily entail adherence, for reasons we 

















































 At Harare Central, the doctors we spent time with estimated that 90-95% of patients 
were prescribed antibiotics. “Rarely a patient goes home without an antibiotic”, remarked 
paediatrician Dr Maware. This is supported by a review of the records of 130 children at this 
hospital, which found that 121 (93%) of children were prescribed at least one antibiotic and 
that 57.5% of these were indicated by EDLIZ (Olaru et al, 2020). The doctors also observed 
that most antibiotics would be prescribed intravenously, and that the most widely used was 
ceftriaxone. The point prevalence survey conducted for the situation analysis found that 
ceftriaxone was the most frequently used at all central hospitals, comprising 35% of total 
antibiotic use (Zimbabwe AMR Core Group, 2016). The survey found that ceftriaxone was 
used in 36% of patients for treatment across a broad spectrum of indications. Diagnoses 
likely to result in ceftriaxone use included diseases of the central nervous system (63%), ear, 
nose and throat infections (56%), systemic inflammatory response syndrome (50%), obstetric 
and gynaecological infections (44%) and pneumonia (39%).  
 
Navigating Guidelines in Practice 
Views of EDLIZ 
The bedrock of medical curricula in Zimbabwe, EDLIZ was intimately familiar to the 
healthcare professionals we spent time with and, as Mutizwa-Mangiza (1999) had similarly 
observed of public sector doctors in the 1990s, almost unanimously expressed positive 
opinions of it. Indeed, it was commonly referred to as a medical Bible of sorts, mostly by 
nurses (“That is our Bible” – Nurse, Clinic 1) but by some doctors too, for its detailed 
guidance, dosing information and referral advice. W also noted recognition of and support 
for EDLIZ’s underlying principles and values, notably RDU. As well as often hearing the 










role of EDLIZ in rationalising drug use across the system. Sister Makoma (Clinic 1), for 
instance, observed:   
“When you are working in institutions like this one [Clinic 1], even at 
government hospitals it’s the same thing it’s amoxicillin first [laughs], because 
you have to follow the EDLIZ. Because if you start with something like 
ceftriaxone, then when someone fails on ceftriaxone, you won’t get something in 
public sector to give to that patient” 
The warm feelings towards EDLIZ can be contrasted with those towards the context of its 
current implementation, which respondents juxtaposed with the 1980s–90s. The issues raised 
mapped closely onto those highlighted by Dr Ndou, including medicine shortages (“We used 
to have all the antibiotics, long ago we had all of them – cloxacillin, you name it” – Nurse, 
Clinic 1); the rise of the private and informal sectors exacerbating the misuse of antibiotics 
(“the use of antibiotics was better governed back then” – Pharmacist, Clinic 1); and an 
increase in programmes and paperwork. The IMCI regist r was singled out for being 
especially time consuming and detracting from time caring for patients (“It takes long, it 
actually slows down management” – Nurse, Clinic 2).  
 
Declining Traction of EDLIZ 
During our observations of consultations at clinics and, to some extent Harare Central, 
clinicians consciously pointed out when they did not use antibiotics, often against the norm or 
expectation of an antibiotic being given. For example, after treating a child for a mild ARI, 
Sister Chenai (Clinic 1) said, “I don’t give an antibiotic; I just give a painkiller”. And when 
Sister Chirambo (Clinic 2) treated a child with diarrhoea, she said to the mother she was 










antibiotic is not needed, as she did not look satisfied with what I gave her. You must try to 
explain”. Of course, as Figure 3a suggests, these wer the illnesses for which antibiotics were 
most often ‘overused’. Nurses and doctors related th  concerns that often resulted in non-
indicated prescription:  
“EDLIZ doesn’t allow any antibiotic when you personally assessed and said this 
is mild fever, mild cough or cold...But it’s also difficult! The mother, we try to 
talk with them, you see there’s no consistency in terms of trying to explain the 
signs and symptoms, how it started, and how they will go and care for them at 
home. You’d rather cover them up.” (Facility Manager, Clinic 2) 
“Sometimes you’re just pushed to give an antibiotic for diarrhoea. Because you 
know Harare is an outbreak area for typhoid and other diseases.” (Paediatrician, 
Harare Central) 
The anticipatory use of antibiotics, often described as “covering”, occurred in the well-
documented situation were clinicians feared missing a  infection or complication (e.g. Broom 
et al, 2017; Cabral et al, 2015; Chandler et al, 2012). The reality, we found, was that 
clinicians were faced daily with more complex socio-medical scenarios than were legible to 
the EDLIZ guideline. Not only was the diagnosis often uncertain; patients had paid a steep 
user fee, may already have taken antibiotics, and were expecting medicinal care for a 
condition that was likely severe given that they had come at all. This was backed up by 
numerous examples of when they withheld antibiotics and these same patients had later 
seriously deteriorated. Forced to respond to the demands of context that were illegible to the 
guideline, even the fiercest advocates of RDU were fr quently compelled in to push back 
against the abstractions of the guideline and use antibiotics as structural prophylaxis against 










 While evidence suggests adherence to EDLIZ regarding antibiotics has long been highly 
variable (Table 1), our observations and interviews suggest that it has become increasingly 
difficult to withhold antibiotics in the 21st Century. Dr Roland, a senior physician and HIV 
researcher, strongly advocated risk-averse prescribing because the noxious syndemic 
interactions between HIV, poverty and outbreaks meant that any febrile illness was “very 
likely” to be bacterial, and that therefore the seemingly neat distinction between viral and 
bacterial, promoted by EDLIZ, should be “discarded”. Taking a more moderate position, Dr 
Nakiso (Harare Central) suggested doctors could do more to narrow the likely causes of 
infection in the absence of diagnostics; but with nurses, EDLIZ’s apparent confidence in 
withholding antibiotics amounted to “passing the buck” of systemic uncertainty onto their 
consciences. EDLIZ, indeed, seemed no longer instil the same confidence or had the 
regulatory power that it used to, even within the public sector. With EDLIZ revised only 
every four years or so, not only were programme activities and guidelines often ahead and 
given precedence (see above); EDLIZ revisions were constrained by increasingly sparse data 
and not always sensitive to the disease and resistance profiles clinicians were facing on the 
ground. This drove individual acts of ‘covering’ of the kind that we regularly observed; it had 
also resulted in several instances where the EDLIZ had been overruled by local authorities. 
This includes a flu outbreak in which rates of secondary bacterial infection were so high all 
cases were treated with amoxicillin; and during our fieldwork, Clinic 2 was instructed to treat 
gastroenteritis with metronidazole, accounting for much of the metronidazole use we 
documented (Figure 3b). What our respondents were th r fore pointing towards was a 
widening distance and disconnect of the EDLIZ guideline from Zimbabwean bodies, diseases 










Broad-Spectrum Antibiotics as ‘Quick Fixes’ 
As well as the question of when an antibiotic should be prescribed, we followed debates 
around antibiotic use at different levels of care. Dr Ndou (NMTPAC) explained that one of 
the principles of EDLIZ in the 1980s–90s was that clini  nurses would work with “simple 
antibiotics” such as oral penicillins, and that the“big guns” – broad-spectrum antibiotics that 
were more expensive, had higher resistance potential a d/or more side effects – would be 
reserved for use by doctors. As noted above, however, o r time toward such antibiotics have 
become more widely indicated at lower levels of care, which have often been introduced 
through specific programmes. There are good reasons behind this: ceftriaxone, ciprofloxacin 
and azithromycin for instance have all been introduce  at the primary level because of 
resistance to other drugs and have moreover become nsiderably cheaper since the 2000s. 
At the same time, the danger expressed by Dr Ndou and other health planners we spoke to 
was that, because of resource scarcity, once these antibiotics were in the clinics they would 
then be used for other diseases, often amounting to “shooting budgies with a canon” (Ms 
Thorsen, Pharmacist, ZEDAP). During our fieldwork, we observed that antibiotic selection 
was often determined by stock: broad-spectrum antibiotics were sometimes used when the 
EDLIZ-specified antibiotic was unavailable or alternatively when the broad-spectrum 
antibiotic was nearing expiry and was used to avoid wastage. Additionally, ciprofloxacin was 
sometimes turned to for treating patients with multiple symptoms in the narrow window of 
time they had. For instance, Sister Chenai (Clinic 1), faced with a child with a sore throat, a 
high fever, diarrhoea and vomiting, reassured a worried-looking father: “I covered him with 
[ciprofloxacin] for all the symptoms”. While these practices would be classified by an audit 
as ‘irrational’, they demonstrate how knowledgeable the nurses were to be able to swap 
antibiotics for one another to negotiate resource constraints while still having a reasonable 










 While primary-level antibiotic use was a source of c ncern, the general feeling among 
health planners, scientists and facility managers wa that nurses were doing well under the 
circumstances to prescribe in line with EDLIZ, while hospital-level use by doctors was a 
greater challenge. Central hospitals were indeed to be the first targets of AMS following the 
national action, with plans to establish therapeutic committees underway. A particular focus 
in this regard has been the (over)use of ceftriaxone. Looking into the reasons for the 
prominence of ceftriaxone today, senior clinicians recalled that in the 1990s, when the health 
system and economy were more stable, benzylpenicilli  was the most widely used antibiotic, 
often given with gentamicin or chloramphenicol; ceftriaxone was then still a specialist drug. 
Interestingly, while we found current discussions around ceftriaxone overuse have tended to 
emphasise ‘irrational’ individual behaviour – doctors too lazy to do proper histories, not 
acting on available blood results, bowing to patient pressure – it is perhaps no coincidence 
that the ascendency of ceftriaxone in the 2000s has mirrored the decline of the system around 
it. First, ceftriaxone has better treatment outcomes for meningitis caused by Streptococcus 
pneumoniae than benzylpenicillin in the absence of susceptibility testing, especially in 
settings with high levels of penicillin non-susceptibility (Gouveia et al. 2017), a better safety 
profile than chloramphenicol and good penetration into cerebrospinal fluid. Jokingly referred 
to as “jik” or “domestos” (thick bleach), doctors explained that ceftriaxone was an ideal 
antibiotic given the country’s eroded laboratory capacity. Second, it only needs administering 
once or twice daily (cf. 4–6x daily for benzylpenicill n), reducing the burden on limited staff. 
Finally, from being an expensive drug only available in the public sector via foreign donors, 
it has become cheaper to rival benzylpenicillin, catalysing its ‘downward’ trajectory in 
EDLIZ. Reflecting on these attributes, Dr Roland exclaimed “it was made for Africa! It fills 










so long now been relied on as a ‘quick fix’ for care (Denyer Willis & Chandler, 2019) that 
they no longer fill gaps in the system but now are the system.  
 
Discussion 
This article provides an important additional perspctive on the struggle to optimise antibiotic 
use in health care settings. Adding to the existing evidence base that characterises 
behavioural as well as structural ‘drivers’ of antibiotic use (Broom et al, 2020; Chandler, 
2019; Will, 2018), here, we focused on everyday scripts through which antibiotics articulate 
healthcare. Through a historically informed ethnography of antibiotics in the Zimbabwean 
health system, we identify the ways in which the RDU programme embedded antibiotics – 
and their misuse – in particular ways that have continuity and differences with current AMS 
efforts. Drawing on a range of primary and secondary, qualitative and quantitative data, our 
following of the evolving notion of ‘(ir)rationality’ along temporal and spatial axes reveals 
how the layering and retracing of imperatives, practices, models and programmes have come 
to form global health ‘architectures’ (Dixon & Chandler 2019; Herrick & Reubi 2017). Here, 
the ideology of antibiotic use as a form of rationality continues, even while we observe a 
substantial shift in the focus of previous RDU programmes – set out to protect patient safety 
and the public purse – and more recent AMS programmes – set out to protect the efficacy of 
medicines themselves.  
 Anthropologists and other social scientists have contested biomedical constructions of 
‘(ir)rationality’ for espousing one-dimensional renderings of antibiotic use that neglects 
context and history (e.g. Broom et al, 2017; Pearson & Chandler, 2019; Rodrigues, 2020). 
Our analysis supports these critiques but goes further by applying the same contextual lens to 
the construct of ‘irrationality’ itself, revealing dynamic, evolving and not-so-obviously 










RDU and essential drugs were configured together within a utopian set of aspirations to build 
robust health systems in LMICs in which essential drugs would be affordable, available and 
appropriately used. In Zimbabwe, this vision was written into the EDLIZ guideline, upon 
which the country’s once-renowned healthcare system was built, facilitated by the proactive, 
bottom-up initiatives of ZEDAP (Laing & Ruredzo, 1989). Even through economic decline, 
EDLIZ remains central to the organisation of medical education and care, and actors across 
the system remain advocates of EDLIZ and the principles of RDU, tending not to see 
‘rationality’ simply as a matter of individual behaviour but as an attribute of a functioning 
health system towards which Zimbabwe aspired towards in the 1980s and early 1990s. At the 
same time, however, EDLIZ, as a treatment guideline melded with a medicine list, has long 
reinforced the centrality of medicines to care (Greene 2015), the implementation of which 
was evaluated by surveillance techniques that were focused primarily on prescribing 
outcomes. Whilst these technologies once painted Zimbabwe as a model for the promotion of 
rational use (WHO, 1995), their representations of practice have been neither broad nor 
reflexive enough to adequately respond to the increasing resource scarcity, privatisation and 
the whittling away of care to medicines that have made EDLIZ increasingly difficult update 
and to follow. Specifically, we highlighted the challenges the NMTPAC faced centrally 
managing antibiotic selection and use amidst the fragmentary, technological logics of global 
health and, in turn, the increasing importance of antibiotics to prescribers as structural 
prophylaxis and as ‘canons’/‘bleach’ in the face of vulnerability, immediacy, precarity and 
infrastructural pharmaco-dependency. 
Anthropologists have observed that, while the phenomenon of AMR presents 
opportunity to bring into view and challenge the infrastructural role antimicrobials have taken 
on in place of more sustainable interventions, paradoxically what has occurred is a doubling 










costs (Chandler, Hutchinson & Hutchison, 2016). What sets the current discourses around 
AMR apart from those around 20th Century RDU is the heightened emphasis on global he lt  
security: we are locked in a ‘war on superbugs’ travelling porously across the globe and 
whose treatment in one place can undermine that in the ext (Nerlich & James, 2009). 
Against the dystopian threat of entering a ‘post-antibiotic apocalypse’, the inherited language 
of ‘irrationality’ appears to be playing a discursive role fuelling blame of people in ‘other’ 
places (Brown & Nettleton, 2015) and shifting conversations away from vulnerable people 
towards vulnerable medicines (Chandler, Hutchinson & Hutchison, 2016). Offering initial 
insights into the grooves through which these new scurity configurations are moving, we 
showed how AMR discourse has entered Zimbabwe throug  a cut-and-paste approach driven 
by international agencies and selectively connected up with the country’s pre-existing RDU 
infrastructure. Whereas the RDU programmes driven by ZEDAP in the 20th Century were 
aspirational, bottom up and oriented towards building a strong healthcare system, existing 
and planned AMS programmes in Zimbabwe are defensiv, firefighting and top-down and 
appear more a tool for fighting the ‘war on superbugs’ than (re)building the country’s 
fragmented and dilapidated healthcare system. Yet in its selective blindness to the ‘normal 
emergency’ (Feireman, 2011) within which clinicians must provide care, the language of 
‘rationality’ is not simply a deficient framework, for as a global politics of knowledge 
imposed on the local is highly productive in its own right. Flipped without attention to 
context, it produces the local ‘irrationalities’ that are being configured as targets for 
restrictive and corrective intervention. In the process, despite prima facie tensions with 
pharmaceuticalisation, the framework of ‘(ir)rationality’ has paradoxically become part of an 
architecture sustaining the centrality of pharmaceuti als. While this may serve interests of 
powerful actors in the global north, we contend that is may, in the end, make the explicit 










 As we have shown throughout this article, however, the current global health 
architecture shaping responses to AMR is neither inevitable nor entirely determinative of 
present and future action. Building on social sciene critiques of AMS (e.g. Broom et al, 
2020), our work calls for a reformed AMS framework that reverses the gaze currently trained 
on individual behaviour and turns it back not only upon the economic and political contexts 
of care but upon the architecture of global health itself. Such a reformed AMS means 
designing-out our reliance on antibiotics as a replacement for care and functioning healthcare 
systems, and simultaneously designing-back-in a fuller picture of care that foregrounds 
clinical attentiveness, non-medicinal care (e.g. concern, support, information) and disease 
prevention. At the same time, there are no ‘quick fixes’ for this and, given the systematic 
neglect of poverty, dilapidated infrastructure and multiple forms of structural violence, by the 
time patients are within the gaze of a health worker th y likely do need antibiotics. In such 
scenarios, neat distinctions between viral and bacteri l – a persisting feature of clinical 
guidelines – often end up passing systemic uncertainty onto the consciences of frontline 
prescribers. Instead of labelling these practices ‘irrational’, we must take their contextual 
knowledge seriously, and equip them with accurate, up-to-date data on disease and 
susceptibility and thereby restore, perhaps, some of the faith in ‘medical bibles’ like EDLIZ. 
While surveillance data is a core component of the current AMS framework, we stress that 
the emphasis should be not on resistance (what doesn’t work) but rather susceptibility (what 
does). As our data suggests, most of the antibiotics being prescribed, especially at clinic 
level, are old, “simple” agents. Determining where th se antibiotics are efficacious – in 
contrast to the tendency to quickly move to the ever “bigger guns” – is important for 
supporting health workers to manage illnesses that,while more likely to be bacterial than in 











Conclusion   
In the context of global concerns around AMR, much is at stake in the way that this broad 
and extremely complex policy object is framed – whether it is a problem of structures, 
systems and transnational inequalities, or as a problem of ‘irrational’ behaviours on the part 
of individual antibiotic (ab)users. This article traces a slightly different track by focusing on 
the everyday scripts through which antibiotics come to articulate care in the global south. Our 
wide-angle ethnographic perspective on the emergent architecture of global health as it 
relates to antibiotic use in Zimbabwe illustrates the struggle to optimise antibiotic use within 
current framings for action. We propose a reconfiguring of the architecture of global health 
such that frontline prescribers are able to provide ‘good’ care without necessarily turning to 
antibiotics. To design-out antibiotic reliance would require attention beyond rationality, to the 




Ahmad R., Zhu, N.J., Leather, A.J.M., Holmes, A., Ferlie E., et al. (2019). Strengthening 
strategic management approaches to address antimicrobial esistance in global human 
health: a scoping review. BMJ Global Health, 4, e001730 
Akpan, Mary R., Nsisong U. Isemin, Arit E. Udoh, and D. Ashiru-Oredope 
2020. Implementation of antimicrobial stewardship programmes in African countries: 
a systematic literature review. Journal of Global Antimicrobial Resistance, 22, 317-
324 










Aung, Z. (2019). An evaluation of antibiotic prescribing and guideline compliance in adults 
presenting to primary health care in Zimbabwe (Unpublished Master’s Thesis), 
University College London, UK 
Geissler, W. (Ed.) (2015). Para-States and Medical Science: Making African Globa  Health. 
Durham and London: Duke University Press.  
Biehl, J. (2006). Pharmaceutical Governance. In Petryna A., Lakoff, A., Kleinman A. (Eds). 
Global Pharmaceuticals: Ethics, Markets, Practices. Durham, NC: Duke University 
Press. 
Broom, A., Broom, J., Kirby, E., Gibson, A., Davis, M. (2017). Antibiotic optimisation in 
‘the bush’: Local know-how and core-periphery relations. Health and Place, 48, 56-
62. 
Broom, J.A. Broom & Kirby, E. (2019). The drivers of antimicrobial use across institutions, 
stakeholders and economic settings: a paradigm shift i  required for effective 
optimization. Journal of Antimicrobial Chemotherapy, 74(9), 2803-2809. 
Broom, A., Kenny, K., Prainsack, B., & Broom, J. (2020). Antimicrobial resistance as a 
problem of values? Views from three continents. Critical Public Health DOI: 
10.1080/09581596. 1725444.  
Brown, N., & Nettleton, S. (2016). ‘There is worse to come’: The biopolitics of traumatism in 
Antimicrobial Resistance. The Sociological Review, 65(3), 493–508  
Cabral, C., Lucas, P. J., Ingram, J., Hay, A. D., & Horwood, J. (2015). “It's safer to …” 










respiratory tract infections: An analysis across four qualitative studies. Social Science 
& Medicine, 136–137, 156-164. 
Chandler, C.I.R., Hutchinson, E., & Hutchison, C. (2016). Addressing Antimicrobials 
through Social Theory: An Anthropologically Oriented Report, London: London 
School of Hygiene and Tropical Medicine. Retrieved from 
http://app.lshtm.ac.uk/files/2016/11/LSHTMAnthroAMR-2016.pdf. 
Chandler, C.I.R. (2019). Current Accounts of Antimicrobial Resistance: Stabilisation, 
Individualisation and Antibiotics as Infrastructure. Palgrave Communications, 
5(53).  
Chigudu, S. (2020). The Political Life of an Epidemic: Cholera, Crisis and Citizenship in 
Zimbabwe. Oxford: Oxford University Press. 
Cox, J. A., Vlieghe, E., Mendelson, M., Wertheim, H. Ndegwa, L., Villegas, M. V., I. Gould 
Hara, G. L. (2017). Antibiotic stewardship in low-and middle-income countries: the 
same but different? Clinical microbiology and infection, 23(11), 812-818. 
Denyer Willis L. & Chandler C.I.R. (2019). Quick fix for care, productivity, hygiene and 
inequality: reframing the entrenched problem of antibio ic overuse. BMJ Global 
Health, 4, e001590. 
Dixon J., Chandler C.I.R. (2019). Opening up ‘fever’, closing down medicines: algorithms as 
blueprints for global health in an era of antimicrobial resistance. Medicine 
Anthropology Theory, 6(4), 53-79.   
Euro Health Group. (2005). Health Sector Support Programme. Zimbabwe: Medicines 










Feierman, S. (2011). When Physicians Meet: Local Medical Knowledge and Global Public 
Goods. In P.W. Geissler (Ed.). Evidence, Ethos and Experiment: The Anthropology 
and History of Medical Research in Africa (pp.171–96). New York: Berghahn Books.   
Geest, S.V.D. & Whyte, S.R. (1989). The Charm of Medicines: Metaphors and Metonyms. 
Medical Anthropology Quarterly, 3(4), 345-367.  
Gouveia, E.L., Reis, J.N., Flannery, B. et al. (2011). Clinical outcome of pneumococcal 
meningitis during the emergence of pencillin-resistant Streptococcus pneumoniae: an 
observational study. BMC Infectious Diseases, 11, 323. 
Gouws E., Bryce J., Habicht J.P., et al. (2004). Improving antimicrobial use among health 
workers in first-level facilities: results from the multi-country evaluation of the 
integrated management of childhood illness strategy. Bulletin of the World Health 
Organization, 82, 509-15. 
Greene, J. (2015). Vital Objects: Essential Drugs and Their Critical Legacies. S.E. Bell & 
A.E. Figert (Eds.). Reimagining (Bio)Medicalisation, Pharmaceuticalisaton and 
Genetics: Old Critiques and New Engagements (pp.89-111). Routledge: New York 
and London. 
Haenssgen, M.J., Charoenboon, N., Zanello, G., Mayxay, M., Reed-Tsochas, F., Lubell, Y. et 
al. (2019). Antibiotic knowledge, attitudes, and practices: new insights from cross-
sectional rural health behaviour surveys in low- and middle-income Southeast Asia. 
BMJ Open, 9, e028224. 
Hardman, J. (2020). Interventions to Modify Antibiotic Use in Children with Suspected 
Infections in Peripheral Healthcare Settings in LMIC. (Unpublished Master’s Thesis), 










Herrick, C. & Reubi, D. (Eds.). (2017). Global Health and Geographical Imaginaries. 
London and New York: Routledge.  
IACG (Interagency Coordination Group on Antimicrobial Resistance). (2019). No Time to 
Wait: Securing the Future From Drug-Resistant Infections: Report To the Secretary-
General of the United Nations. Retrieved from https://www.who.int/antimicrobial-
resistance/interagency-coordination-group/final-repo t/en/ 
Johansson, E.W., Selling, K.E., Nsona, H., Mappin, B., Gething, P.W., Petzold, M., Peterson, 
S.S. & Hildenwall, H. (2016). Integrated Paediatric Fever Management and Antibiotic 
Over-Treatment in Malawi Health Facilities: Data Mining a National Facility Census. 
Malaria Journal, 15(1), 1-12.  
Kidia, K.K. (2018). The future of health in Zimbabwe. Global Health Action, 11(1), 
1496888.  
Klein, E.Y., van Boeckel, T.P., Martinez, E.M., Pant, S., Gandra, S., Levin, S.A., Goossens, 
H., Laxminarayan, R. (2017). Global increase and geographic convergence in 
antibiotic consumption between 2000 and 2015. Proc. Natl. Acad. Sci., 115(15), 
17295. 
Krockow, E.M. & Tarrant, C. (2020). The international dimensions of antimicrobial 
resistance: Contextual factors shape distinct ethical challenges in South Africa, Sri 
Lanka and the United Kingdom. Bioethics, 33(7), 756-765. 
Laing, R. (1990). Rational drug use: An unsolved problem. Tropical Doctor. 20(3), 101-103.   
Laing, R. (2003). 25 years of the WHO essential medicines lists: progress and 










Laing, R. & Ruredzo, R. (1989). The essential drugs programme in Zimbabwe: New 
approaches to training. Health Policy and Planning, 4(3), 229-234.  
Lawson, T. (1997). Situated Rationality. Journal of Economic Rationality, 4(1): 101-125. 
Ledingham, K.,  Hinchliffe, S. & Jackson, M. 2019. Antibiotic resistance: using a cultural 
contexts of health approach to address a global heat  challenge. Geneva, 
Switzerland: World Health Organisation.  
Loewenson, R, Sanders, D., Davies, R. (1991). Challenges to equity in health and health care: 
A Zimbabwean case study. Social Science and Medicine, 32(10), 1079-1088.  
 Marcus, G.E. (1995). Ethnography in/of the World System: The Emergence of Multi-Sited 
Ethnography. Annual Review of Anthropology, 24, 95-117.   
Mashalla, Y., Setlhare, V., Massele, A., Sepako, E., Tiroyakgosi, C., Kgatlwane, J., Chuma, 
M. & Godman, B. (2017). Assessment of prescribing practices at the primary 
healthcare facilities in Botswana with an emphasis on antibiotics: Findings and 
implications. International Journal of Clinical Practice, 71(12), 1-10. 
Mutizwa-Mangiza, N.D. (1999). Doctors and the State: The Struggle for Professional 
Control in Zimbabwe. London: Ashgate.  
Nerlich, B. & James, R. (2009). ''The post-antibiotic apocalypse'' and the ''war on superbugs'': 
catastrophe discourse in microbiology, its rhetorical form and political function. 
Public Understanding of Science, 18, 574-590. 
OIE (World Organisation for Animal Health). (2016). The OIE Strategy on Antimicrobial 












Olaru I.D., Meierkord A., Godman B., Ngwenya C., Fitzgerald F., Dondo V., Ferrand R.A., 
Kranzer K. (2020). Assessment of antimicrobial use and prescribing practices among 
pediatric inpatients in Zimbabwe. Journal of Chemotherapy, Mar 2:1-4. 
O’Neill, J. (2016). Tackling Drug-Resistant Infections Globally: Final Report and 
Recommendations. The Review on Antimicrobial Resistance. Chaired by Jim O’Neill. 
London: The Review on Antimicrobial Resistance. Retrieved from https://amr-
review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf. 
Pearson, M. & Chandler, C.I.R. (2019) Knowing antimicrobial resistance in practice: a multi-
country qualitative study with human and animal healthc re professionals, Global 
Health Action, 12(1), 1599560. 
Podolsky, S. (2015). The Antibiotic Era: Reform, Resistance, and the Pursuit of a Rational 
Therapeutics. Baltimore: Johns Hopkins University Press. 
Rowe, A.K., Rowe, S.Y., Peters, D.H., Holloway, K.A., Chalker, J., Ross-Degnan, D. 
(2018). Effectiveness of strategies to improve healt -care provider practices in low-
income and middle-income countries: a systematic review. Lancet Global Health, 
6(11), e1163-e1175.  
Sulis, G., Adam, P., Nafade, V., Gore, G., Daniels, B., Daftary, A., Das, J., Gandra, S., & Pai, 
M. (2020). Antibiotic prescription practices in primary care in low- and middle-
income countries: A systematic review and meta-analysis. PLoS Medicine, 










 Trap, B, Chinyanganya, F.W., Nathoo, K.J., Chidarikire, A. (1997). Indicator studies, a 
powerful and useful management tool in the planning, monitoring and evaluation of 
essential drugs programmes. Retrieved from 
http://archives.who.int/icium/icium1997/posters/4b3_text.html 
Trap, B, Hansen, E.H. & Hogerzeil, H.V. (2002). Prescription habits of dispensing and non-
dispensing doctors in Zimbabwe. Health Policy and Planning, 17(3), 288-295. 
Van Dijck, C., Vliegheb, E., Cox., J.A. (2017). Antibiotic stewardship interventions in 
hospitals in low-and middle-income countries: a systematic review. Bulletin of the 
World Health Organisation, 96: 266-280.  
WHO. (1977). The Selection of Essential Drugs. WHO Technical Report Series no. 615. 
Geneva: World Health Organization. Retrieved from 
https://apps.who.int/iris/bitstream/handle/10665/4136 /WHO_TRS_641.pdf;jsessioni
d=1FC675915D71620FA49CB987AB0D94B7?sequence=1 
WHO & INRUD. (1993). How to investigate drug use in health facilities: Selected drug use 
indicators. WHO/DAP/93.1. Geneva: World Health Organiz tion. Retrieved from 
https://www.who.int/medicines/publications/how-to-investigate_drug-use/en/ 
WHO. (2009). Antimicrobial Resistance: Global Report on Surveillance. Geneva: World 
Health Organisation. Retrieved from 
https://www.who.int/drugresistance/documents/surveillancereport/en/ 
WHO. (2015). Global Action Plan on Antimicrobial Resistance. Geneva: World Health 











Whyte, S.R., Van der Geest, S., & Hardon, A. (2002). Social Lives of Medicines. Cambridge: 
Cambridge University Press.  
Wilkinson, A., Ebata, A. & MacGregor, H. (2018). Interventions to Reduce Antibiotic 
Prescribing in LMICs: A Scoping Review of Evidence from Human and Animal 
Health Systems. Antibiotics, 8(2):1-25.  
Will, C.M. (2018). Beyond behavior? Institutions, interactions and inequalities in the 
response to antimicrobial resistance. Sociology of health & illness, 40(3), E1-E9.  
Woelk, G.. (1994). Primary healthcare in Zimbabwe: Can it Survive? An Exploration of the 
Political and Historical Developments Affecting the Implementation of PHC. Social 
Science and Medicine, 39(8), 1027-1035. 
World Bank. (2019). Drug-Resistant Infections: A Threat to Our Economic Future. Retrieved 
from https://www.worldbank.org/en/topic/health/publication/drug-resistant-
infections-a-threat-to-our-economic-future 
ZEDAP (Zimbabwe Essential Drugs Action Programme) and the MoHCC (Ministry of 
Health and Child Welfare, Zimbabwe). (1995).  Fourteen Years with an Essential 
Drugs List: Zimbabwe's Experience. Essential Drugs Monitor, 19, 17-18.  
Zimbabwe MoHCC (Ministry of Health and Child Welfare). (1984). Planning for Equity in 
Health: A Sectoral Review and Policy Statement. Government Printers, Harare. 
Zimbabwe Antimicrobial Resistance Core Group. (2016). Situation Analysis on 













Zimbabwe AMR Core Group. (2017). Zimbabwe One Health Antimicrobial Resistance 















Table 1. Prescribing indicators from national surveys 1991–1993 (Trap et al, 1997), 1995–
2004 (Euro Health Group, 2005) and 2011–2015 (AMR Core Group, 2016). Surveyed  
facilities included central, provincial and distric hospitals and primary facilities. 
Methodology based on WHO/INRUD (1993) indicators. Data presented combine all facility 























Mild ARI 77 60 51 82 30 56 49 22 33 
Diarrhoea - 48.5 45 53 62 21 27 23 45 
Number of medicines per 
prescription 
1.3 1.7 1.7 1.8 2.1 2.1 2 2 2.1 
Patients prescribed 
antibiotics (%) 
- 42 42 41 48 60 34 69 35 
Availability of essential 
medicines (%) 






















Table 2. Consultation and prescription data captured at Clinics 1 and 2 
          * Nurses estimated that the optimal time needed to perf rm a complete consultation was around 15-25 
Variable Clinic 1 Clinic 2 
Consultations (n) 370 371 
Consultation length* (Mean 
mins, range) 
7.5 (3–30) 9.3 (1–35) 
Antibiotic prescription (%) 207 (56%) 217 (58%) 
Febrile patients (fraction and % 
prescribed antibiotics) 
60/69 (87%) 41/56 (73%) 
Males (n, % of n received 
antibiotics) 
170 (61%) 174 (60%) 
Females (n, % of n prescribed 
antibiotics) 
200 (51%) 197 (57%) 
Mean Age (Range) 27 (0.12–88) 20 (0.08–87) 
 < 5 Yrs (n, % of n received 
antibiotics) 
92 (55%) 155 (55%) 
≥ 5 Yrs (n, % of n received 
antibiotics %)  

























Figure 1. Map of Harare showing the population density of the city’s suburbs and the 










































• Antibiotics have been cumulatively designed-in to the architecture of global health 
• Ethnography in Zimbabwe documents the evolution of struggles to optimise use 
• Guideline developers tasked with reconciling ‘rational’ use with increasing 
pharmaceuticalisation  
• For prescribers, antibiotics are ‘big guns’, ‘thick bleach’ and ‘cover’ for unknowns  
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